⚠️

Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.

Read our methodology →

Jonathan RitvoM.D.

Neuropsychiatry · Denver, CO 80246

NPI: 1376516252

Share:𝕏fin

38

🟠 Elevated

Risk Flags

Extreme opioid rate vs specialty peersHigh long-acting opioid rate vs peersElevated antipsychotic prescribing (65+)

Risk indicators are statistical patterns, not allegations. Learn more

435

Total Claims

$70K

Drug Cost

31

Beneficiaries

$2,270

Cost/Patient

Risk Score Breakdown 38/100

Low (0)Moderate (15)Elevated (30)High (50+)
Opioid rate vs specialty peers+25
Long-acting opioid rate+8
Elderly antipsychotic prescribing+5

Score components are additive. Read full methodology

Peer Comparison vs. 1,619 Neuropsychiatry providers

+82%

Cost per patient vs peers

$2,270 vs $1,249 avg

+80%

Brand preference vs peers

9.7% vs 5.4% avg

⚠️ This provider has metrics more than 3 standard deviations above their specialty average in one or more categories.

Opioid Prescribing

20.7%

Opioid Rate

90

Opioid Claims

$49K

Opioid Cost

25.6%

Long-Acting Rate

This provider's opioid prescribing rate of 20.7% is above the 20% threshold that CMS considers elevated.

Brand vs Generic

90% generic

Brand: 42 claims · $56K

Generic: 393 claims · $14K

Patient Profile

71

Avg Age

36%

Female

1.24

Avg Risk Score

Explore More

Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About